ATLANTA, GA – – (Globe Newswire – November 6, 2024) – – A shareholder class action lawsuit has been filed against Metagenomi, Inc. (“Metagenomi” or “the Company”) (NASDAQ: MGX). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information in Metagenomi’s Registration Statement concerning the Company’s collaboration agreement with Moderna, resulting in harm to investors.

If you bought shares of Metagenomi on or after the Company’s February 13, 2024 IPO, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/metagenomi/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is November 25, 2024.